Identification of an Internalizing Cancer Target for Novel Antibody Drug Conjugate Development by A&G Pharmaceutical and Precision Antibody Researchers
COLUMBIA, Maryland, February 10, 2021: Precision Antibody and A&G Pharmaceutical are pleased to announce the publication, in PLOS One, of the results of their collaborative study